Amundi MSCI World Ex USA UCITS ETF (LON:WEXU)
London · Delayed Price · Currency is GBP · Price in GBX 958.70
-1.75 (-0.18%)
At close: Apr 2, 2026
22.10% (1Y)
| Assets | 468.59M |
| Expense Ratio | 0.16% |
| PE Ratio | 17.78 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +22.10% |
| Volume | 7,927 |
| Open | 947.60 |
| Previous Close | 960.45 |
| Day's Range | 947.20 - 961.08 |
| 52-Week Low | 692.41 |
| 52-Week High | 1,018.20 |
| Beta | n/a |
| Holdings | 774 |
| Inception Date | Sep 3, 2024 |
About WEXU
WEXU.DE was created on 2024-09-03 by Amundi. The fund's investment portfolio concentrates primarily on total market equity. The objective of this Sub-Fund is to track the performance of MSCI World ex USA Index (the Index), and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Index. The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund.
Asset Class Equity
Category Total Market
Stock Exchange London Stock Exchange
Ticker Symbol WEXU
Provider Amundi
Index Tracked MSCI World ex USA
Performance
WEXU had a total return of 22.10% in the past year, including dividends. Since the fund's inception, the average annual return has been 16.00%.
Top 10 Holdings
12.17% of assets| Name | Symbol | Weight |
|---|---|---|
| ASML Holding N.V. | ASML | 2.25% |
| AstraZeneca PLC | AZN | 1.29% |
| Novartis AG | NOVN | 1.25% |
| Roche Holding AG | ROP | 1.21% |
| HSBC Holdings plc | HSBA | 1.20% |
| Shell plc | SHEL | 1.16% |
| Nestlé S.A. | NESN | 1.09% |
| Royal Bank of Canada | RY | 0.97% |
| Toyota Motor Corporation | 7203 | 0.89% |
| Commonwealth Bank of Australia | CBA | 0.87% |